| Patent | Date |
|---|
Covalent Diabodies and Uses Thereof
App 20220275082 - Johnson; Leslie S. ; et al. | 2022-09-01 |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
Grant 11,421,031 - Koenig , et al. August 23, 2 | 2022-08-23 |
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
Grant 11,384,149 - Johnson , et al. July 12, 2 | 2022-07-12 |
Dosing Regimens of Bispecific CD123 x CD3 Diabodies in the Treatment of Hematologic Malignancies
App 20220213203 - Davidson; Jan Kenneth ; et al. | 2022-07-07 |
Combination Therapy for the Treatment of Cancer
App 20220204625 - Vasselli; James ; et al. | 2022-06-30 |
FcgammaRIIB-Specific Antibodies and Methods of Use Thereof
App 20220177574 - Johnson; Leslie S. ; et al. | 2022-06-09 |
Pharmaceutical Compositions of a HER2/neu Antibody and Use of the Same
App 20220177602 - Farb; David Lee ; et al. | 2022-06-09 |
Methods And Compositions For Treatment Of Lupus
App 20220162306 - Leon; Francisco ; et al. | 2022-05-26 |
HER2/neu-Specific Antibodies and Methods of Using Same
App 20220089773 - Johnson; Leslie S. ; et al. | 2022-03-24 |
CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3
App 20220056131 - Huang; Ling ; et al. | 2022-02-24 |
Covalent diabodies and uses thereof
Grant 11,254,748 - Johnson , et al. February 22, 2 | 2022-02-22 |
Covalent diabodies and uses thereof
Grant 11,254,747 - Johnson , et al. February 22, 2 | 2022-02-22 |
Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and LAG-3, and Methods of Use Thereof
App 20220041714 - Bonvini; Ezio ; et al. | 2022-02-10 |
Combination Therapy for the Treatment of Cancer
App 20220041725 - Wigginton; Jon Marc ; et al. | 2022-02-10 |
ADAM9-binding molecules, and methods of use thereof
Grant 11,242,402 - Loo , et al. February 8, 2 | 2022-02-08 |
Bispecific CD123 x CD3 Diabodies for the Treatment of Hematologic Malignancies
App 20210395374 - Davidson; Jan Kenneth ; et al. | 2021-12-23 |
Immunoconjugates Targeting Adam9 And Methods Of Use Thereof
App 20210388102 - Hicks; Stuart William ; et al. | 2021-12-16 |
Combination therapy for the treatment of cancer
Grant 11,174,315 - Vasselli , et al. November 16, 2 | 2021-11-16 |
Immunoconjugates Targeting Adam9 And Methods Of Use Thereof
App 20210275685 - Hicks; Stuart William ; et al. | 2021-09-09 |
CD3-binding molecules capable of binding to human and non-human CD3
Grant 11,111,299 - Huang , et al. September 7, 2 | 2021-09-07 |
Fc.gamma.RIIB-specific antibodies and methods of use thereof
Grant 11,098,125 - Johnson , et al. August 24, 2 | 2021-08-24 |
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof
Grant 11,098,119 - Bonvini , et al. August 24, 2 | 2021-08-24 |
Optimized gp41-Binding Molecules and Uses Thereof
App 20210246194 - Lam; Chia-Ying Kao ; et al. | 2021-08-12 |
Combination therapy for the treatment of cancer
Grant 11,078,279 - Wigginton , et al. August 3, 2 | 2021-08-03 |
LAG-3-binding molecules and methods of use thereof
Grant 11,072,653 - La Motte-Mohs , et al. July 27, 2 | 2021-07-27 |
LAG-3-Binding Molecules and Methods of Use Thereof
App 20210206851 - La Motte-Mohs; Ross ; et al. | 2021-07-08 |
Bispecific CD16-Binding Molecules and Their Use in the Treatment of Disease
App 20210171630 - Diedrich; Gundo ; et al. | 2021-06-10 |
Novel B7-h3 Binding Molecules, Antibody Drug Conjugates Thereof And Methods Of Use Thereof
App 20210171641 - LOO; Deryk T. ; et al. | 2021-06-10 |
HER2/neu-specific antibodies and methods of using same
Grant 11,028,183 - Johnson , et al. June 8, 2 | 2021-06-08 |
Variant CD3-Binding Domains and Their Use in Combination Therapies for the Treatment of Disease
App 20210155694 - Bonvini; Ezio ; et al. | 2021-05-27 |
Methods Of Using Bispecific Molecules Having Immunoreactivity With Pd-1 And Ctla-4
App 20210130470 - JOHNSON; Leslie S. ; et al. | 2021-05-06 |
Compound Targeting Il-23a And B-cell Activating Factor (baff) And Uses Thereof
App 20210107998 - SINGH; Sanjaya ; et al. | 2021-04-15 |
Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof
App 20210095021 - Koenig; Scott ; et al. | 2021-04-01 |
B7-H3 binding molecules, antibody drug conjugates thereof and methods of use thereof
Grant 10,961,311 - Loo , et al. March 30, 2 | 2021-03-30 |
Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof
Grant 10,954,301 - Johnson , et al. March 23, 2 | 2021-03-23 |
Dosing Regiments of Bi-Specific CD123 x CD3 Diabodies in the Treatment of Hematologic Malignancies
App 20210061911 - Wigginton; Jon Marc ; et al. | 2021-03-04 |
Compound Targeting Il-23a And Tnf-alpha And Uses Thereof
App 20210054065 - Barrett; Rachel Rebecca ; et al. | 2021-02-25 |
Bi-Specific Monovalent Diabodies That are Capable of Binding CD123 and CD3, and Uses Thereof
App 20210047426 - Bonvini; Ezio ; et al. | 2021-02-18 |
Methods for the Treatment of Disease Using Immunoglobulins Having Fc Regions with Altered Affinities for FcgammaRactivating and FcgammaRinhibiting
App 20200392245 - Stavenhagen; Jeffrey B. ; et al. | 2020-12-17 |
Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof
Grant 10,858,430 - Moore , et al. December 8, 2 | 2020-12-08 |
Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof
App 20200377612 - Johnson; Leslie S. ; et al. | 2020-12-03 |
Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof
Grant 10,844,138 - Singh , et al. November 24, 2 | 2020-11-24 |
Bispecific Molecules Comprising An Hiv-1 Envelope Targeting Arm
App 20200354439 - HAYNES; Barton F. ; et al. | 2020-11-12 |
Compound targeting IL-23A and TNF-alpha and uses thereof
Grant 10,793,629 - Barrett , et al. October 6, 2 | 2020-10-06 |
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof
Grant 10,787,521 - Bonvini , et al. September 29, 2 | 2020-09-29 |
Combination Therapy
App 20200255524 - Kind Code | 2020-08-13 |
Antibodies reactive with B7-H3 and users thereof
Grant 10,730,945 - Johnson , et al. | 2020-08-04 |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
Grant 10,730,947 - Koenig , et al. | 2020-08-04 |
Pd-1-binding Molecules And Methods Of Use Thereof
App 20200231675 - Shah; Kalpana ; et al. | 2020-07-23 |
Bispecific molecules comprising an HIV-1 envelope targeting arm
Grant 10,717,778 - Haynes , et al. | 2020-07-21 |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for Fc.gamma.R.sub.activating and Fc.gamma.R.sub.inhibiting
Grant 10,711,069 - Stavenhagen , et al. | 2020-07-14 |
Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses Thereof
App 20200216537 - Johnson; Leslie S. ; et al. | 2020-07-09 |
Multi-chain Polypeptide-containing Tri-specific Binding Molecules That Specifically Bind To Multiple Cancer Antigens
App 20200207850 - JOHNSON; Leslie S. ; et al. | 2020-07-02 |
Tri-specific Binding Molecules That Specifically Bind To Multiple Cancer Antigens And Methods Of Use Thereof
App 20200199223 - BONVINI; Ezio ; et al. | 2020-06-25 |
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
Grant 10,683,364 - Johnson , et al. | 2020-06-16 |
Multi-chain polypeptide-containing tri-specific binding molecules
Grant 10,647,768 - Johnson , et al. | 2020-05-12 |
FcgammaRIIB-Specific Antibodies and Methods of Use Thereof
App 20200131265 - Koenig; Scott ; et al. | 2020-04-30 |
Multi-chain polypeptide-containing tri-specific binding molecules that specifically bind to multiple cancer antigens
Grant 10,633,440 - Bonvini , et al. | 2020-04-28 |
Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof
Grant 10,633,443 - Johnson , et al. | 2020-04-28 |
Anti-pd-1 Antibodies And Uses Thereof
App 20200095322 - Cornfeld; Mark ; et al. | 2020-03-26 |
Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life
App 20200095333 - Bonvini; Ezio ; et al. | 2020-03-26 |
PD-1-binding molecules and methods of use thereof
Grant 10,577,422 - Shah , et al. | 2020-03-03 |
Bispecific Binding Molecules That Are Capable Of Binding Cd137 And Tumor Antigens, And Uses Thereof
App 20200062854 - LIU; Liqin ; et al. | 2020-02-27 |
Combination Therapy for the Treatment of Cancer
App 20190389952 - Vasselli; James ; et al. | 2019-12-26 |
ADAM9-Binding Molecules, and Methods of Use Thereof
App 20190382502 - Loo; Deryk T. ; et al. | 2019-12-19 |
Multivalent molecules comprising DR5-binding domains
Grant 10,501,552 - Moore , et al. Dec | 2019-12-10 |
BCR-complex-specific antibodies and methods of using same
Grant 10,479,831 - Johnson , et al. Nov | 2019-11-19 |
Methods for the Use of CD32B x CD79B-Binding Molecules in the Treatment of Inflammatory Diseases and Disorders
App 20190322741 - Chen; Wei ; et al. | 2019-10-24 |
Bi-Specific Monovalent Fc Diabodies That Are Capable of Binding CD32B and CD79b and Uses Thereof
App 20190270813 - Johnson; Leslie S. ; et al. | 2019-09-05 |
Compound Targeting Il-23a And B-cell Activating Factor (baff) And Uses Thereof
App 20190241678 - SINGH; Sanjaya ; et al. | 2019-08-08 |
HER2/neu-Specific Antibodies and Methods of Using Same
App 20190233539 - Johnson; Leslie S. ; et al. | 2019-08-01 |
FcgammaRIIB-Specific Antibodies and Methods of Use Thereof
App 20190218288 - Johnson; Leslie S. ; et al. | 2019-07-18 |
Bi-specific monovalent Fc diabodies that are capable of binding CD32B and CD79b and uses thereof
Grant 10,344,092 - Johnson , et al. July 9, 2 | 2019-07-09 |
Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and LAG-3, and Methods of Use Thereof
App 20190169292 - Bonvini; Ezio ; et al. | 2019-06-06 |
Bispecific Molecules Having Immunoreactivity with PD-1 and CTLA-4, and Methods of Use Thereof
App 20190161548 - Johnson; Leslie S. ; et al. | 2019-05-30 |
Compound targeting IL-23A and B-cell activating factor (BAFF) and uses thereof
Grant 10,280,231 - Singh , et al. | 2019-05-07 |
PD-1-Binding Molecules and Methods of Use Thereof
App 20190127467 - Shah; Kalpana ; et al. | 2019-05-02 |
Novel B7-h3 Binding Molecules, Antibody Drug Conjugates Thereof And Methods Of Use Thereof
App 20190127471 - LOO; Deryk T. ; et al. | 2019-05-02 |
Covalent Diabodies and Uses Thereof
App 20190092860 - Johnson; Leslie S. ; et al. | 2019-03-28 |
Covalent Diabodies and Uses Thereof
App 20190092859 - Johnson; Leslie S. ; et al. | 2019-03-28 |
LAG-3-Binding Molecules and Methods of Use Thereof
App 20190085075 - La Motte-Mohs; Ross ; et al. | 2019-03-21 |
CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3
App 20190040135 - Huang; Ling ; et al. | 2019-02-07 |
Compound Targeting Il-23a And Tnf-alpha And Uses Thereof
App 20190016794 - Barrett; Rachel Rebecca ; et al. | 2019-01-17 |
Antibodies with Altered Binding to FcRn and Methods of Using Same
App 20190010243 - Gorlatov; Sergey | 2019-01-10 |
Bispecific Monovalent Diabodies That are Capable of Binding B7-H3 and CD3, and Uses Thereof
App 20190002563 - Johnson; Leslie S. ; et al. | 2019-01-03 |
Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life
App 20180371104 - Bonvini; Ezio ; et al. | 2018-12-27 |
Covalently bonded diabodies having immunoreactivity with PD-1 and LAG-3, and methods of use thereof
Grant 10,160,806 - Bonvini , et al. Dec | 2018-12-25 |
CD3-binding molecules capable of binding to human and non-human CD3
Grant 10,150,812 - Huang , et al. Dec | 2018-12-11 |
HER2/neu-specific antibodies and methods of using same
Grant 10,131,713 - Johnson , et al. November 20, 2 | 2018-11-20 |
Combination Therapy for the Treatment of Cancer
App 20180298100 - Wigginton; Jon Marc ; et al. | 2018-10-18 |
Methods for the treatment of vascularizing cancers
Grant 10,100,115 - Chi October 16, 2 | 2018-10-16 |
Fc.gamma.RIIB-specific antibodies and methods of use thereof
Grant 10,100,116 - Johnson , et al. October 16, 2 | 2018-10-16 |
Covalent diabodies and uses thereof
Grant 10,093,739 - Johnson , et al. October 9, 2 | 2018-10-09 |
Covalent diabodies and uses thereof
Grant 10,093,738 - Johnson , et al. October 9, 2 | 2018-10-09 |
Compound targeting IL-23A and TNF-alpha and uses thereof
Grant 10,059,763 - Barrett , et al. August 28, 2 | 2018-08-28 |
Covalent Diabodies And Uses Thereof
App 20180194840 - JOHNSON; Leslie S. ; et al. | 2018-07-12 |
Bispecific Molecules That Are Immunoreactive With Immune Effector Cells That Express An Activating Receptor And An Antigen Expressed By A Cell Infected By A Virus And Uses Thereof
App 20180155423 - Koenig; Scott ; et al. | 2018-06-07 |
Bispecific Molecules Comprising An Hiv-1 Envelope Targeting Arm
App 20180148497 - HAYNES; Barton F. ; et al. | 2018-05-31 |
Antibodies Reactive with B7-H3 and Uses Thereof
App 20180134790 - Johnson; Leslie S. ; et al. | 2018-05-17 |
Covalent diabodies and uses thereof
Grant 9,963,510 - Johnson , et al. May 8, 2 | 2018-05-08 |
Bi-Specific Monovalent Diabodies That are Capable of Binding to gpA33 and CD3, and Uses Thereof
App 20180118824 - Moore; Paul A. ; et al. | 2018-05-03 |
Combination of FcgammaRIIB-Specific Antibodies and CD20-Specific Antibodies and Methods of Use Thereof
App 20180092978 - Tuaillon; Nadine ; et al. | 2018-04-05 |
Bi-Specific Monovalent Diabodies That are Capable of Binding CD123 and CD3, and Uses Thereof
App 20180094072 - Bonvini; Ezio ; et al. | 2018-04-05 |
Bi-specific monovalent diabodies that are capable of binding to gpA33 and CD3, and uses thereof
Grant 9,932,400 - Moore , et al. April 3, 2 | 2018-04-03 |
Bispecific molecules that are immunoreactive with immune effector cells that express an activating receptor and an antigen expressed by a cell infected by a virus and uses thereof
Grant 9,908,938 - Koenig , et al. March 6, 2 | 2018-03-06 |
BCR-Complex-Specific Antibodies and Methods of Using Same
App 20180051079 - Johnson; Leslie S. ; et al. | 2018-02-22 |
Antibodies reactive with B7-H3 and uses thereof
Grant 9,896,508 - Johnson , et al. February 20, 2 | 2018-02-20 |
Covalently-associated diabody complexes that possess charged coil domains and that are capable of enhanced binding to serum albumin
Grant 9,889,197 - Johnson , et al. February 13, 2 | 2018-02-13 |
Multivalent Molecules Comprising DR5-Binding Domains
App 20180016344 - Moore; Paul A. ; et al. | 2018-01-18 |
Methods for the Treatment of Disease Using Immunoglobulins Having Fc Regions with Altered Affinities for FcgammaRactivating and FcgammaRinhibiting
App 20180009902 - Stavenhagen; Jeffrey B. ; et al. | 2018-01-11 |
Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof
App 20170362333 - Johnson; Leslie S. ; et al. | 2017-12-21 |
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3, and uses thereof
Grant 9,822,181 - Bonvini , et al. November 21, 2 | 2017-11-21 |
Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses Thereof
App 20170247452 - Johnson; Leslie S. ; et al. | 2017-08-31 |
Combination of Fc.gamma.RIIB-specific antibodies and CD20-specific antibodies and methods of use thereof
Grant 9,737,599 - Tuaillon , et al. August 22, 2 | 2017-08-22 |
ROR1-Binding Molecules, and Methods of Use Thereof
App 20170233472 - Barat; Bhaswati ; et al. | 2017-08-17 |
HER2/neu-Specific Antibodies and Methods of Using Same
App 20170218083 - Johnson; Leslie S. ; et al. | 2017-08-03 |
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
Grant 9,714,295 - Johnson , et al. July 25, 2 | 2017-07-25 |
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
Grant 9,714,296 - Johnson , et al. July 25, 2 | 2017-07-25 |
Tri-Specific Binding Molecules That Specifically Bind to Multiple Cancer Antigens and Methods of Use Thereof
App 20170204176 - Bonvini; Ezio ; et al. | 2017-07-20 |
Methods for the treatment of disease using immunoglobulins having Fc Regions with altered affinities for Fc.gamma.R.sub.activating and Fc.gamma.R.sub.inhibiting
Grant 9,708,408 - Stavenhagen , et al. July 18, 2 | 2017-07-18 |
Tri-Specific Binding Molecules and Methods of Use Thereof
App 20170198045 - Johnson; Leslie S. ; et al. | 2017-07-13 |
Covalently Bonded Diabodies Having Immunoreactivity with PD-1 and LAG-3, and Methods of Use Thereof
App 20170198037 - Bonvini; Ezio ; et al. | 2017-07-13 |
BCR-complex-specific antibodies and methods of using same
Grant 9,695,236 - Johnson , et al. July 4, 2 | 2017-07-04 |
Bi-Specific Monovalent Diabodies That are Capable of Binding CD19 and CD3, and Uses Thereof
App 20170157251 - Bonvini; Ezio ; et al. | 2017-06-08 |
CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3
App 20170137519 - Huang; Ling ; et al. | 2017-05-18 |
CD3-binding molecules capable of binding to human and non-human CD3
Grant 9,587,021 - Huang , et al. March 7, 2 | 2017-03-07 |
B7-H3L cell surface antigen and antibodies that bind thereto
Grant 9,574,007 - Mather , et al. February 21, 2 | 2017-02-21 |
Compound Targeting Il-23a And B-cell Activating Factor (baff) And Uses Thereof
App 20170022294 - SINGH; SANJAYA ; et al. | 2017-01-26 |
Covalent Diabodies and Uses Thereof
App 20160355586 - Johnson; Leslie S. ; et al. | 2016-12-08 |
Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life
App 20160333111 - Bonvini; Ezio ; et al. | 2016-11-17 |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
Grant 9,487,587 - Koenig November 8, 2 | 2016-11-08 |
HER2/neu-specific antibodies and methods of using same
Grant 9,469,692 - Johnson , et al. October 18, 2 | 2016-10-18 |
Antibodies with Altered Binding to FcRn and Methods of Using Same
App 20160289333 - Gorlatov; Sergey | 2016-10-06 |
Antibodies Reactive with B7-H3 and Uses Thereof
App 20160264672 - Johnson; Leslie S. ; et al. | 2016-09-15 |
Antibodies reactive with B7-H3 and uses thereof
Grant 9,441,049 - Johnson , et al. September 13, 2 | 2016-09-13 |
HER2/neu-Specific Antibodies and Methods of Using Same
App 20160257761 - Koenig; Scott ; et al. | 2016-09-08 |
Bi-Specific Monovalent Diabodies That are Capable of Binding to gpA33 and CD3, and Uses Thereof
App 20160222105 - Moore; Paul A. ; et al. | 2016-08-04 |
Bi-Specific Monovalent Diabodies That are Capable of Binding CD123 and CD3, and Uses Thereof
App 20160200827 - Bonvini; Ezio ; et al. | 2016-07-14 |
Bi-Specific Monovalent Fc Diabodies That Are Capable of Binding CD32B and CD79b and Uses Thereof
App 20160194396 - Johnson; Leslie S. ; et al. | 2016-07-07 |
Deimmunized serum-binding domains and their use in extending serum half-life
Grant 9,376,495 - Bonvini , et al. June 28, 2 | 2016-06-28 |
Covalent Diabodies and Uses Thereof
App 20160159908 - Johnson; Leslie S. ; et al. | 2016-06-09 |
HER2/neu-Specific Antibodies and Methods of Using Same
App 20160130360 - Johnson; Leslie S. ; et al. | 2016-05-12 |
Covalent diabodies and uses thereof
Grant 9,296,816 - Johnson , et al. March 29, 2 | 2016-03-29 |
Covalent diabodies and uses thereof
Grant 9,284,375 - Johnson , et al. March 15, 2 | 2016-03-15 |
Compound Targeting Il-23a And Tnf-alpha And Uses Thereof
App 20160060338 - BARRETT; RACHEL REBECCA ; et al. | 2016-03-03 |
Methods for the Treatment of Autoimmune Disorders Using Immunosuppressive Monoclonal Antibodies with Reduced Toxicity
App 20160046714 - Koenig; Scott ; et al. | 2016-02-18 |
HER2/neu-specific antibodies and methods of using the same
Grant 9,243,069 - Johnson , et al. January 26, 2 | 2016-01-26 |
Bispecific Molecules That are Immunoreactive with Immune Effector Cells That Express an Activating Receptor and an Antigen Expressed by a Cell Infected by a Virus and Uses Thereof
App 20160017038 - Koenig; Scott | 2016-01-21 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20150344575 - Koenig; Scott ; et al. | 2015-12-03 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20150344574 - Koenig; Scott ; et al. | 2015-12-03 |
Antibodies reactive with B7-H3, immunologically active fragments thereof and uses thereof
Grant 9,150,656 - Johnson , et al. October 6, 2 | 2015-10-06 |
Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof
App 20150274838 - Johnson; Leslie S. ; et al. | 2015-10-01 |
Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof
App 20150259434 - Johnson; Leslie S. ; et al. | 2015-09-17 |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
App 20150259396 - Stavenhagen; Jeffrey B. ; et al. | 2015-09-17 |
Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
Grant 9,096,877 - Johnson , et al. August 4, 2 | 2015-08-04 |
Deimmunized Serum-Binding Domains and Their Use in Extending Serum Half-Life
App 20150175697 - Bonvini; Ezio ; et al. | 2015-06-25 |
BCR-Complex-Specific Antibodies and Methods of Using Same
App 20150166658 - Johnson; Leslie S. ; et al. | 2015-06-18 |
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
Grant 9,056,906 - Koenig , et al. June 16, 2 | 2015-06-16 |
Identification and engineering of antibodies with variant FC regions and methods of using same
Grant 9,028,815 - Stavenhagen , et al. May 12, 2 | 2015-05-12 |
BCR-complex-specific antibodies and methods of using same
Grant 8,993,730 - Johnson , et al. March 31, 2 | 2015-03-31 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,968,730 - Koenig , et al. March 3, 2 | 2015-03-03 |
Identification and engineering of antibodies with variant Fc regions and methods of using same
Grant 8,951,517 - Stavenhagen , et al. February 10, 2 | 2015-02-10 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,946,387 - Koenig , et al. February 3, 2 | 2015-02-03 |
FcgammaRIIB-Specific Antibodies and Methods of Use Thereof
App 20150023964 - Johnson; Leslie S. ; et al. | 2015-01-22 |
Antibodies Reactive with B7-H3 and Uses Thereof
App 20140328750 - Johnson; Leslie S. ; et al. | 2014-11-06 |
HER2/neu-Specific Antibodies and Methods of Using Same
App 20140328836 - Johnson; Leslie S. ; et al. | 2014-11-06 |
Combination of FcgammaRIIB-Specific Antibodies and CD20-Specific Antibodies and Methods of Use Thereof
App 20140328843 - Tuaillon; Nadine ; et al. | 2014-11-06 |
Bispecific Molecules That Are Immunoreactive with Immune Effector Cells of a Companion Animal That Express an Activating Receptor and Cells That Express B7-H3 and Uses Thereof
App 20140255407 - Koenig; Scott | 2014-09-11 |
Antibodies reactive with B7-H3 and uses thereof
Grant 8,802,091 - Johnson , et al. August 12, 2 | 2014-08-12 |
HER2/neu-specific antibodies and methods of using same
Grant 8,802,093 - Johnson , et al. August 12, 2 | 2014-08-12 |
Compositions for the prevention and treatment of smallpox
Grant 8,795,667 - Johnson , et al. August 5, 2 | 2014-08-05 |
Fc.gamma.RIIB--specific antibodies and methods of use thereof
Grant 8,785,599 - Johnson , et al. July 22, 2 | 2014-07-22 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,784,808 - Johnson , et al. July 22, 2 | 2014-07-22 |
Combination of Fc.gamma.RIIB-specific antibodies and CD20-specific antibodies and methods of use thereof
Grant 8,778,339 - Tuaillon , et al. July 15, 2 | 2014-07-15 |
Methods for the Treatment of Disease Using Immunoglobulins Having Fc Regions with Altered Affinities for FcgammaRactivating and FcgammaRinhibiting
App 20140134162 - Stavenhagen; Jeffrey B. ; et al. | 2014-05-15 |
Identification and engineering of antibodies with variant Fc regions and methods of using same
Grant 8,697,071 - Stavenhagen , et al. April 15, 2 | 2014-04-15 |
CD3-Binding Molecules Capable of Binding to Human and Non-Human CD3
App 20140099318 - Huang; Ling ; et al. | 2014-04-10 |
BCR-complex-specific antibodies and methods of using same
Grant 8,669,349 - Johnson , et al. March 11, 2 | 2014-03-11 |
Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity
Grant 8,663,634 - Koenig , et al. March 4, 2 | 2014-03-04 |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for Fc.gamma.R.sub.activating and Fc.gamma.R.sub.inhibiting
Grant 8,652,466 - Stavenhagen , et al. February 18, 2 | 2014-02-18 |
BCR-Complex-Specific Antibodies and Methods of Using Same
App 20140017237 - Johnson; Leslie S. ; et al. | 2014-01-16 |
Covalent Diabodies and Uses Thereof
App 20130295121 - Johnson; Leslie S. ; et al. | 2013-11-07 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,530,627 - Koenig , et al. September 10, 2 | 2013-09-10 |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
App 20130202606 - Stavenhagen; Jeffrey ; et al. | 2013-08-08 |
Antibodies Reactive with B7-H3, Immunologically Active Fragments Thereof and Uses Thereof
App 20130149236 - Johnson; Leslie S. ; et al. | 2013-06-13 |
Identification and engineering of antibodies with variant Fc regions and methods of using same
Grant 8,445,645 - Stavenhagen , et al. May 21, 2 | 2013-05-21 |
KID3 and KID3 antibodies that bind thereto
Grant 8,440,197 - Liang , et al. May 14, 2 | 2013-05-14 |
Antibodies Reactive with B7-H3 and Uses Thereof
App 20120294796 - Johnson; Leslie S. ; et al. | 2012-11-22 |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
App 20120276094 - STAVENHAGEN; JEFFREY ; et al. | 2012-11-01 |
Humanized Fc Gamma Riib-specific Antibodies And Methods Of Use Thereof
App 20120269811 - JOHNSON; LESLIE S. ; et al. | 2012-10-25 |
Engineering Fc Antibody Regions to Confer Effector Function
App 20120263711 - Stavenhagen; Jeffery ; et al. | 2012-10-18 |
Fc Region-Containing Polypeptides That Exhibit Improved Effector Function Due To Alterations Of The Extent Of Fucosylation, And Methods For Their Use
App 20120219551 - Johnson; Leslie S. ; et al. | 2012-08-30 |
Antibodies to oncostatin M receptor
Grant 8,216,578 - Mather , et al. July 10, 2 | 2012-07-10 |
Identification and engineering of antibodies with variant Fc regions and methods of using same
Grant 8,217,147 - Stavenhagen , et al. July 10, 2 | 2012-07-10 |
TES7 and antibodies that bind thereto
Grant 8,216,570 - Mather , et al. July 10, 2 | 2012-07-10 |
Engineering Fc antibody regions to confer effector function
Grant 8,216,574 - Stavenhagen , et al. July 10, 2 | 2012-07-10 |
Humanized Fc.gamma.RIIB-specific antibodies and methods of use thereof
Grant 8,216,579 - Johnson , et al. July 10, 2 | 2012-07-10 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20120141476 - Johnson; Leslie S. ; et al. | 2012-06-07 |
Identification and engineering of antibodies with variant Fc regions and methods of using same
Grant 8,192,737 - Stavenhagen , et al. June 5, 2 | 2012-06-05 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,193,318 - Koenig , et al. June 5, 2 | 2012-06-05 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,187,593 - Koenig , et al. May 29, 2 | 2012-05-29 |
Transferrin receptor antibodies
Grant 8,187,594 - Mather , et al. May 29, 2 | 2012-05-29 |
Antibodies that bind to EphA2 and methods of use thereof
Grant 8,183,357 - Mather , et al. May 22, 2 | 2012-05-22 |
Animal Model for Toxicology and Dose Prediction
App 20120110682 - Mather; Jennie P. ; et al. | 2012-05-03 |
Humanized Antibodies Against West Nile Virus And Therapeutic And Prophylactic Uses Thereof
App 20120070429 - Johnson; Leslie S. ; et al. | 2012-03-22 |
Methods and compositions for generating human monoclonal antibodies
Grant 8,137,668 - Li March 20, 2 | 2012-03-20 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,133,982 - Johnson , et al. March 13, 2 | 2012-03-13 |
T-Cell Receptor Antibodies And Methods of Use Thereof
App 20120034221 - Bonvini; Ezio ; et al. | 2012-02-09 |
FcGammaRIIB Specific Antibodies and Methods of Use Thereof
App 20120009186 - Koenig; Scott ; et al. | 2012-01-12 |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
App 20110305714 - Stavenhagen; Jeffrey ; et al. | 2011-12-15 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 8,044,180 - Koenig , et al. October 25, 2 | 2011-10-25 |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
App 20110243941 - Stavenhagen; Jeffrey ; et al. | 2011-10-06 |
Identification and engineering of antibodies with variant Fc regions and methods of using same
Grant 8,003,774 - Stavenhagen , et al. August 23, 2 | 2011-08-23 |
CD16A Binding Proteins and Use for the Treatment of Immune Disorders
App 20110152504 - Johnson; Leslie S. ; et al. | 2011-06-23 |
Identification and engineering of antibodies with variant Fc regions and methods of using same
Grant 7,960,512 - Stavenhagen , et al. June 14, 2 | 2011-06-14 |
Dual Expression Vector System for Antibody Expression in Bacterial and Mammalian Cells
App 20110136689 - Johnson; Leslie Sydnor ; et al. | 2011-06-09 |
BCR-Complex-Specific Antibodies And Methods Of Using Same
App 20110117089 - Johnson; Leslie S. ; et al. | 2011-05-19 |
Her2/neu-Specific Antibodies and Methods of Using Same
App 20110097323 - Johnson; Leslie S. ; et al. | 2011-04-28 |
Dual expression vector system for antibody expression in bacterial and mammalian cells
Grant 7,906,327 - Johnson , et al. March 15, 2 | 2011-03-15 |
CD16A binding proteins and use for the treatment of immune disorders
Grant 7,838,635 - Johnson , et al. November 23, 2 | 2010-11-23 |
KID3 and KID3 antibodies that bind thereto
Grant 7,790,855 - Liang , et al. September 7, 2 | 2010-09-07 |
Humanized Fc.gamma.RIIB-specific antibodies and methods of use thereof
Grant 7,786,270 - Johnson , et al. August 31, 2 | 2010-08-31 |
Antibodies that bind to EphA2 and methods of use thereof
Grant 7,776,328 - Mather , et al. August 17, 2 | 2010-08-17 |
TES7 and antibodies that bind thereto
Grant 7,718,774 - Mather , et al. May 18, 2 | 2010-05-18 |
Fc.gamma.RIIB fusion proteins and compositions thereof
Grant 7,700,100 - Johnson , et al. April 20, 2 | 2010-04-20 |
Engineering Fc Antibody regions to confer effector function
Grant 7,632,497 - Stavenhagen December 15, 2 | 2009-12-15 |
CD16A binding proteins and use for the treatment of immune disorders
Grant 7,618,628 - Johnson , et al. November 17, 2 | 2009-11-17 |
Humanized antibodies against West Nile Virus and therapeutic and prophylactic uses thereof
Grant 7,572,456 - Johnson , et al. August 11, 2 | 2009-08-11 |
Humanized Fc.gamma.RIIB-specific antibodies and methods of use thereof
Grant 7,521,542 - Johnson , et al. April 21, 2 | 2009-04-21 |
Fc.gamma.RIIB specific antibodies and methods of use thereof
Grant 7,425,619 - Koenig , et al. September 16, 2 | 2008-09-16 |
Identification and engineering of antibodies with variant Fc regions and methods of using same
Grant 7,355,008 - Stavenhagen , et al. April 8, 2 | 2008-04-08 |
CD16A binding proteins and use for the treatment of immune disorders
Grant 7,351,803 - Johnson , et al. April 1, 2 | 2008-04-01 |
Dual expression vector system for antibody expression in bacterial and mammalian cells
Grant 7,112,439 - Johnson , et al. September 26, 2 | 2006-09-26 |
| 